領展與法巴及星展首次簽訂可持續發展表現掛勾英鎊貸款
領展(00823.HK)之管理人─領展資產管理今日(14日)宣布,分別與法國巴黎銀行及星展銀行簽訂,將去年8月達成的兩項合共二億英鎊5年期貸款,轉為與可持續發展表現掛勾的貸款。這是領展首次簽訂以英鎊為貨幣單位的可持續發展表現掛勾貸款。
領展去年8月分別與法國巴黎銀行及星展簽訂兩項英鎊貸款,為領展收購倫敦金絲雀碼頭辦公大樓The Cabot提供部分融資。The Cabot是領展在英國首項收購的資產。有關貸款款項用作一般企業用途,包括實踐可持續發展的倡議。貸款在轉為與可持續發展表現掛勾後,如領展在預先議定的可持續發展表現範疇中達標,即可獲得貸款利率下調,以鼓勵落實可持續發展計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.